Clinical characteristics and treatment response of pulmonary cryptococcosis in HIV negative patients

D. S. Hyun, K. C. Kim, S. C. Lee (Daegu, Republic Of Korea)

Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Session: Aetiology and diagnosis of lower respiratory tract infections
Session type: Thematic Poster Session
Number: 2400
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. S. Hyun, K. C. Kim, S. C. Lee (Daegu, Republic Of Korea). Clinical characteristics and treatment response of pulmonary cryptococcosis in HIV negative patients. Eur Respir J 2009; 34: Suppl. 53, 2400

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical characteristics of immunocompetent patients with pulmonary cryptococcosis
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012

Clinical and morphological outcomes of pulmonary tuberculosis concurrent with chronic hepatitis
Source: Eur Respir J 2006; 28: Suppl. 50, 13s
Year: 2006

Clinical presentation and outcome in pulmonary tuberculosis with diabetes about 39 cases
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008

Clinical analysis of 76 patients pathologically diagnosed with pulmonary cryptococcosis
Source: Eur Respir J 2012; 40: 1191-1200
Year: 2012



Clinical profile and outcome of complicated pulmonary tuberculosis in children
Source: Eur Respir J 2002; 20: Suppl. 38, 362s
Year: 2002

Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015

Does the radiological manifestation of drug resistant pulmonary tuberculosis (PTB) in HIV non-infected/infected patients differ – an Indian picture
Source: Eur Respir J 2007; 30: Suppl. 51, 440s
Year: 2007

Clinical characteristics of paradoxical response to chemotheraphy in pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 520s
Year: 2003

Safety of the endobronchial valve use in the complex treatment of patients with destructive MDR/XDR TB associated with HIV infection.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


Does the clinical symptoms of drug resistant pulmonary tuberculosis (PTB) act as a predictor in HIV non-infected/infected patient? An Indian scenario
Source: Eur Respir J 2006; 28: Suppl. 50, 858s
Year: 2006

Results of treatment of patients with pulmonary tuberculosis combined with HIV infection and hepatitis
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018

Clinical characteristics of surgically-diagnosed pulmonary cryptococcosis
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011


Clinical characteristic of the patients with drug resistant pulmonary tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 661s
Year: 2007

Prevalence of CNS lesions in patients with pulmonary tuberculosis and HIV infection
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019


Pulmonary cryptococcosis in patients without HIV infection: analysis of 14 cases
Source: Eur Respir J 2005; 26: Suppl. 49, 410s
Year: 2005

Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020


Features of tuberculosis incidence and clinical forms for sarcoidosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 202s
Year: 2004

Treatment outcomes of pulmonary tuberculosis cases in Izmit/Turkey
Source: Eur Respir J 2004; 24: Suppl. 48, 651s
Year: 2004

Secondary pulmonary mycoses etiology agent species diversity in patients with tuberculosis and in patients with HIV infection
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020